May 22, 2019 / TheNewswire / Toronto, Ontario - Matica Enterprises Inc. (MMJ - CSE) (39N - Frankfurt) (MMJFF - OTC) ("Matica" or the "Company") is taking the first steps in entering the Canadian adult-use cannabis edibles market. Matica has purchased one hundred per cent (100%) interest in both Trichome Treats Inc. and 10406619 Canada Inc. (together as "Trichome"). Matica, together with Licence Holder, RoyalMax Biotechnology Canada Inc. ("RoyalMax"), will work with Trichome and their award winning chocolatiers to produce a full range of adult-use cannabis infused products. Core Offerings will include cannabis edibles, beverages and infused derivatives, in anticipation of expected legalisation of edibles in October of this year. Matica's initial strategic product development will utilise Trichome's award winning recipes to focus on the chocolate and confectionary market.
"We hope that Trichome's award winning recipes, experience and trademarks will give Matica a brilliant entry into the edibles market. The combination of RoyalMax, Yunify and now Trichome gives Matica a true and diversified platform to provide a wide range of delivery system choices for our future clientele. We will be able to provide not just high quality flower but, also the value added products that cannabis consumers demand. Our acquisition of Trichome is the latest in our strategic partnerships that Matica is developing to create growth and opportunities for our shareholders," says Boris Ziger, CEO, Matica.
Matica has purchased Trichome, with all its recipes, know-how and trademarks. The key personnel at Trichome will work with Matica and RoyalMax to establish an adult-use cannabis division in anticipation of edibles legalisation. The transaction entered into is an all stock transaction for the amount of $500,000 at a deemed price of $0.115. Matica will issue 4,347,826 shares in four tranches based on milestones.
Trevor Hands of Trichome states, "While Matica and RoyalMax will supply the active ingredients, we at Trichome will create the flavours, textures and forms that edibles consumers want. It is up to us to create the overall experience with the right dosing and entourage effect to give adult-users the experience they expect. A premium quality offering will be our goal."
Matica is a multi-faceted, innovative company in the Quebec cannabis space. RoyalMax Biotechnology Canada Inc. has been granted a standard cultivation licence by Health Canada for the production facility in Dorval, Quebec. Matica intends to build 1,000,000 square feet of greenhouses, in 200,000 square foot increments, on a 181 acre property in the township of Hemmingford, south of Montreal. Matica has entered into an agreement with Yunify Natural Technologies, a Quebec based health and personal care research and innovation company to develop proprietary products for Matica and RoyalMax.
For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
Boris Ziger, CEO & Chairman
The Company's public filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, at:
Disclaimer for Forward-Looking Information
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation's filings with the Canadian securities regulators, which filings are available at www.sedar.com.
This news release contains statements about the Company's information that may be made available on the S&P Capital IQ Corporation Records Listing Program and the business of Matica that are forward-looking in nature and as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.